Lineage stability and phenotypic plasticity of Foxp3⁺ regulatory T cells - PubMed
Review
. 2014 May;259(1):159-72.
doi: 10.1111/imr.12175.
Affiliations
- PMID: 24712465
- DOI: 10.1111/imr.12175
Review
Lineage stability and phenotypic plasticity of Foxp3⁺ regulatory T cells
Shohei Hori. Immunol Rev. 2014 May.
Abstract
Regulatory T (Treg) cells expressing the transcription factor forkhead box protein 3 (Foxp3) constitute a unique T-cell lineage committed to suppressive functions. While their differentiation state is remarkably stable in the face of various perturbations from the extracellular environment, they are able to adapt to diverse and fluctuating tissue environments by changing their phenotype. The lineage stability and phenotypic plasticity of Treg cells thus ensure the robustness of self-tolerance and tissue homeostasis. Recent studies have suggested, however, that Treg cells may retain lineage plasticity, the ability to switch their cell fate to various effector T-cell types under certain circumstances such as inflammation, a notion that remains highly contentious. While accumulating evidence indicates that some Treg cells can downregulate Foxp3 expression and/or acquire effector T-helper cell-like phenotypes, results from my laboratory have shown that Treg cells retain epigenetic memory of, and thus remain committed to, Foxp3 expression and suppressive functions despite such phenotypic plasticity. It has also become evident that Foxp3 can be promiscuously and transiently expressed in activated T cells. Here, I argue that the current controversy stems partly from the lack of the lineage specificity of Foxp3 expression and also from the confusion between phenotypic plasticity and lineage plasticity, and discuss implications of our findings in Treg cell fate determination and maintenance.
Keywords: Foxp3; cell fate determination; epigenetic memory; heterogeneity; phenotypic plasticity; regulatory T cells.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Similar articles
-
Developmental plasticity of Foxp3+ regulatory T cells.
Hori S. Hori S. Curr Opin Immunol. 2010 Oct;22(5):575-82. doi: 10.1016/j.coi.2010.08.004. Epub 2010 Sep 9. Curr Opin Immunol. 2010. PMID: 20829012 Review.
-
Regulatory T cell plasticity: beyond the controversies.
Hori S. Hori S. Trends Immunol. 2011 Jul;32(7):295-300. doi: 10.1016/j.it.2011.04.004. Epub 2011 Jun 2. Trends Immunol. 2011. PMID: 21636323
-
Stability of regulatory T-cell lineage.
Hori S. Hori S. Adv Immunol. 2011;112:1-24. doi: 10.1016/B978-0-12-387827-4.00001-2. Adv Immunol. 2011. PMID: 22118405 Review.
-
Developmental plasticity of murine and human Foxp3(+) regulatory T cells.
Liston A, Piccirillo CA. Liston A, et al. Adv Immunol. 2013;119:85-106. doi: 10.1016/B978-0-12-407707-2.00003-5. Adv Immunol. 2013. PMID: 23886065
-
Functional dynamics of Foxp3⁺ regulatory T cells in mice and humans.
Bin Dhuban K, Kornete M, S Mason E, Piccirillo CA. Bin Dhuban K, et al. Immunol Rev. 2014 May;259(1):140-58. doi: 10.1111/imr.12168. Immunol Rev. 2014. PMID: 24712464 Review.
Cited by
-
Moldenhauer LM, Foyle KL, Wilson JJ, Wong YY, Sharkey DJ, Green ES, Barry SC, Hull ML, Robertson SA. Moldenhauer LM, et al. iScience. 2024 Jan 23;27(2):108994. doi: 10.1016/j.isci.2024.108994. eCollection 2024 Feb 16. iScience. 2024. PMID: 38327801 Free PMC article.
-
Verhagen J, Wegner A, Wraith DC. Verhagen J, et al. Immunology. 2015 Jun;145(2):171-81. doi: 10.1111/imm.12458. Immunology. 2015. PMID: 25716063 Free PMC article. Review.
-
Generation, Characteristics and Clinical Trials of Ex Vivo Generated Tolerogenic Dendritic Cells.
Kim SH, Jung HH, Lee CK. Kim SH, et al. Yonsei Med J. 2018 Sep;59(7):807-815. doi: 10.3349/ymj.2018.59.7.807. Yonsei Med J. 2018. PMID: 30091313 Free PMC article. Review.
-
Expression of IL-37 Induces a Regulatory T-Cell-like Phenotype and Function in Jurkat Cells.
Osborne DG, Domenico J, Fujita M. Osborne DG, et al. Cells. 2022 Aug 18;11(16):2565. doi: 10.3390/cells11162565. Cells. 2022. PMID: 36010641 Free PMC article.
-
Development of ImmTOR Tolerogenic Nanoparticles for the Mitigation of Anti-drug Antibodies.
Kishimoto TK. Kishimoto TK. Front Immunol. 2020 May 20;11:969. doi: 10.3389/fimmu.2020.00969. eCollection 2020. Front Immunol. 2020. PMID: 32508839 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources